January 08, - SkinMedica, Inc., a specialty pharmaceutical company focused on dermatology, announced the availability of the Desonate (desonide) Gel 0.05% 120g TwinPack for the treatment of mild to moderate atopic dermatitis. Desonate is a low-potency prescription topical steroid formulated in Dow Pharmaceutical Sciences' proprietary water-based Hydrogel vehicle.
The new economical Desonate TwinPack contains two 60-gram tubes of Desonate Gel for greater coverage of affected areas during the cold-weather season when atopic dermatitis tends to flare most. With the Desonate TwinPack, patients have the added convenience of keeping their medication in two accessible locations. With one prescription, patients can receive twice as much therapy for the same pharmacy co-pay as the smaller tube.
"The Desonate TwinPack provides added value and flexibility to an already effective Desonate therapy," said Dr. Rebecca Smith, Pediatric Dermatologist from a Charlotte, NC suburb. "I have many younger patients cared for by parents in more than one household, and having two tubes of Desonate allows both households to keep Desonate on hand when flares occur. With the new TwinPack, Desonate with Hydrogel continues to provide effective therapy in a cosmetically acceptable, well tolerated formulation."
Clinical studies with Desonate show significant reduction in itching and other symptoms of atopic dermatitis, and Desonate is clinically proven to moisturize and help skin maintain essential hydration by improving the skin barrier.
No comments:
Post a Comment